Table 1.
Total population | |
---|---|
n (%) | 1187 |
Age | 33 (24–44) |
Men, % | 54 |
HbA1c, % | 5.8 (5.5–6.1) |
SBP, mmHg | 118 (108–129) |
Cholesterol, mmol/L | 4.7 (4–5.3) |
HDL chol, mmol/L | 1.2 (1.1–1.5) |
LDL chol, mmol/L | 2.55 (2.0–3.1) |
BMI, kg/m2 | 22.7 (19.5–27.2) |
Waist, cm | 87 (77–97.5) |
ACR, g/molb | 2.58 (0.95–11.25) |
Triglycerides, mmol/Lb | 1.5 (1.0–2.4) |
CRP, mg/Lb | 6 (2–11) |
eGFR, mL/min/1.73 m2 b | 108.9 (95.5–121.5) |
Current smoker, % | 72 |
Microalbuminuria, %c | 29 |
Macroalbuminuria, %d | 15 |
Hypertension, %e | 28 |
Dyslipidaemia, %f | 45 |
Number of clinic visits in the previous 12 months | |
High (>15)a | 17 (204) |
Moderate (5–15)a | 39 (463) |
Low (<5)a | 43 (513) |
CVD historya | 5.2 (62) |
Median (25th–75th percentiles) unless otherwise stated. SBP, systolic blood pressure; HDL, high-density lipoproteins; LDL, low-density lipoproteins; BMI, body mass index; ACR, albumin/creatinine ratio; CRP, C-reactive protein; eGFR, estimated glomerular filtration rate.
a% (n).
bGeometric mean (95% CI).
cACR 3.4–33 g/mol.
dACR ≥ 34 g/mol.
eDyslipidaemia was defined by a previous diagnosis of high cholesterol, taking cholesterol management medication, or having total cholesterol ≥ 5.5 mmol/L or HDL < 1.0 mmol/L.
fHypertension was defined if the participant had a previous diagnosis of hypertension in their health records, was taking antihypertensive medication, or had elevated levels in the baseline examination (≥140 mmHg systolic, ≥90 mmHg diastolic).